See this page online at: http://www.biotechfocus.com/2007Issue8
Sign up for your free subscription and keep up-to-date.
Stay updated on the latest news and technologies with Bioscienceworld's newsletters.
Five to choose from.
|
The Next Revolution: Amorphics - The Science of Protein Misfolding
By George Adams Ph.D and Neil Cashman M.D.
Our understanding of proteins and its functions has advanced through a series of technological and scientific revolutions over the past 50 years: direct sequencing of proteins, to nucleic acid sequencing, to proteomics for rapid identification of proteins and currently to structural genomics for the three-dimensional structure of proteins. |
|
High-Resolution Melting Curve Analysis Novel Strategies For PCR-Based Mutation Scanning and Genotyping
By Michael Hoffmann, Karine Raymond and Jochen Hurlebaus
Post-PCR melting curve analysis (MCA) has become a robust and well-established method to characterize gene fragments, e.g., for microbiological identification or the detection of mutations and single nucleotide polymorphisms (SNPs). |
|
Manufacturing Success
By Shawn Lawrence
Graeme Macaloney, QSV president and CEO knows exactly where the safe money in biotech is. With 22 years of pharma, biotech and entrepreneurial experience spanning management and governance roles in genomic and proteomic organizations he has learned this much. |
|
A Q&A with Ontario Institute for Cancer Research, president and scientific director, Dr. Thomas Hudson
By Shawn Lawrence
In this month's edition of Q&A, Ontario Institute for Cancer Research President and Scientific Director Dr. Thomas Hudson discusses the OICR's role within the framework of this agreement and how it relates to its mandate as well as the implications of the deal in terms of advancing the quest for a cure for cancer and cancer research in Canada. |